BTT Medical Institute, in collaboration with BTT
Author: Michael
Celularity and MuseCell Innovations announced a U
Celularity and MuseCell Innovations announced a U
AlzeCure will present at the Pareto Securities 17
Seven months after ditching paper screening for
Oligonucleotide drug slows Alzheimer’s decline
Oura Health is preparing for a potential U.S.
Oura Health is preparing for a potential U.S.
Retro Biosciences is expanding its phase 1 safety
Insilico Medicine released interim results for th